Osamu Takeuchi Selected Research

RNA Virus Infections

1/2010	LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.
2/2008	MDA5/RIG-I and virus recognition.
1/2008	Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88.
4/2007	TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity.
7/2006	Essential role of IPS-1 in innate immune responses against RNA viruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Takeuchi Research Topics

Disease

27	Infections 01/2017 - 10/2002
25	Inflammation (Inflammations) 12/2022 - 05/2002
16	Virus Diseases (Viral Diseases) 01/2017 - 01/2004
15	Neoplasms (Cancer) 12/2022 - 02/2002
8	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 11/2009
6	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 02/2006
6	Melanoma (Melanoma, Malignant) 01/2015 - 05/2006
5	RNA Virus Infections 01/2010 - 07/2006
4	Ulcerative Colitis 08/2021 - 10/2018
4	Fibrosis (Cirrhosis) 01/2021 - 12/2003
4	Sepsis (Septicemia) 10/2013 - 12/2004
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
3	Hemorrhage 01/2022 - 05/2003
3	Bites and Stings (Sting) 01/2022 - 12/2009
3	Immune System Diseases (Immune Disorders) 11/2021 - 01/2006
2	Bacterial Infections (Bacterial Infection) 12/2022 - 10/2014
2	Shock 12/2022 - 11/2002
2	Necrosis 02/2022 - 07/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 12/2008
2	Adenocarcinoma 01/2019 - 04/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2002
2	Neoplasm Metastasis (Metastasis) 01/2017 - 04/2013
2	Colitis 06/2013 - 11/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2012 - 12/2008
2	Granuloma 12/2009 - 03/2004
2	Nephritis 09/2009 - 12/2008
2	Malaria 01/2007 - 01/2005
2	Colonic Neoplasms (Colon Cancer) 12/2005 - 09/2005
2	Lewis Lung Carcinoma 02/2003 - 02/2002
1	Multiple Sclerosis 11/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Leukopenia 11/2021
1	Residual Neoplasm 01/2021

Drug/Important Bio-Agent (IBA)

22	CytokinesIBA 11/2022 - 08/2002
16	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2002
13	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2004
10	Messenger RNA (mRNA)IBA 10/2021 - 02/2002
9	Antiviral Agents (Antivirals)IBA 01/2015 - 01/2006
9	Interferon Type IIBA 03/2011 - 07/2005
7	InterferonsIBA 01/2021 - 06/2004
7	Gemcitabine FDA Link 12/2020 - 11/2009
7	Pattern Recognition ReceptorsIBA 01/2017 - 03/2004
7	Phosphotransferases (Kinase)IBA 01/2015 - 06/2004
6	LigandsIBA 01/2017 - 07/2004
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2010 - 05/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2006
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 02/2002
5	Interleukin-6 (Interleukin 6)IBA 06/2019 - 02/2002
5	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2006
5	LipopolysaccharidesIBA 01/2015 - 01/2004
5	Double-Stranded RNA (RNA, Double Stranded)IBA 06/2013 - 06/2004
5	Nucleic AcidsIBA 03/2011 - 01/2006
4	Pharmaceutical PreparationsIBA 01/2016 - 11/2009
4	EndotoxinsIBA 05/2010 - 11/2002
4	Toll-Like Receptor 2IBA 09/2005 - 08/2002
3	Ribonucleases (Ribonuclease)IBA 11/2022 - 04/2009
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2011
3	Checkpoint Kinase 1IBA 09/2020 - 06/2012
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2019 - 05/2015
3	Interleukin-12 (IL 12)IBA 02/2004 - 10/2002
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022 - 05/2009
2	EndoribonucleasesIBA 11/2021 - 10/2021
2	Biological ProductsIBA 12/2020 - 05/2010
2	prexasertibIBA 09/2020 - 01/2020
2	Interleukin-4 (Interleukin 4)IBA 12/2017 - 09/2003
2	C-Type Lectins (C-Type Lectin)IBA 01/2017 - 03/2010
2	NLR ProteinsIBA 01/2017 - 03/2010
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 11/2009
2	InflammasomesIBA 04/2014 - 11/2008
2	Viral RNAIBA 07/2013 - 04/2007
2	Interferon-gamma (Interferon, gamma)IBA 06/2012 - 02/2004
2	AntigensIBA 07/2011 - 05/2009
2	pristane (pristan)IBA 02/2011 - 12/2008
2	NF-kappa B (NF-kB)IBA 05/2010 - 07/2003
2	Antigen-Antibody Complex (Immune Complex)IBA 09/2009 - 12/2008
2	Poly I-CIBA 08/2009 - 01/2004
2	ChemokinesIBA 08/2009 - 05/2002
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2008 - 12/2003
2	Interleukin-18 (Interleukin 18)IBA 11/2008 - 10/2002
2	RNA Helicases (RNA Helicase)IBA 07/2008 - 10/2005
2	hemozoinIBA 01/2007 - 01/2005
2	Complementary DNA (cDNA)IBA 09/2005 - 02/2002
1	CyclinsIBA 12/2022
1	human regnase-1IBA 11/2022
1	3' Untranslated Regions (3' UTR)IBA 11/2022
1	Photosensitizing Agents (Photosensitizers)IBA 02/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	NucleotidesIBA 11/2021
1	2-mercaptopurineIBA 11/2021
1	Diphosphates (Pyrophosphates)IBA 11/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 08/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021

Therapy/Procedure

6	Therapeutics 01/2021 - 11/2009
2	Drug Therapy (Chemotherapy) 12/2020 - 02/2002
2	Laparotomy 04/2013 - 03/2005
2	Immunotherapy 04/2008 - 02/2003
2	Hepatectomy 01/2008 - 05/2003
1	Photochemotherapy (Photodynamic Therapy) 02/2022